Frequent pathway mutations of splicing machinery in myelodysplasia

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625

Sequencing technologies – the next generation

Metzker, M. L. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2626 · Cited by 7,066

Next-generation DNA sequencing

Shendure, J., & Ji, H. (2008) · Nature Biotechnology · doi:10.1038/nbt1486 · Cited by 4,509

The Spliceosome: Design Principles of a Dynamic RNP Machine

Wahl, M. C., Will, C. L., & Lührmann, R. (2009) · Cell · doi:10.1016/j.cell.2009.02.009 · Cited by 2,665

Recurring mutations found by sequencing an acute myeloid leukemia genome

Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219

DNMT3A Mutations in Acute Myeloid Leukemia

Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

Morin, R. D., Johnson, N. A., Severson, T., Mungall, A. J. J., An, J., Goya, R., Paul, J. E., Boyle, M., Woolcock, B. W., Kuchenbauer, F. C., et al. (2010) · Nature Genetics · doi:10.1038/ng.518 · Cited by 1,719

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

Puente, X. S., Pinyol, M., Quesada, V., Conde, L., Ordóñez, G. R., Villamor, N., Escaramís, G., Jares, P., Beà, S., González, M., et al. (2011) · Nature · doi:10.1038/nature10113 · Cited by 1,529

Initial genome sequencing and analysis of multiple myeloma

Chapman, M. A., Lawrence, M. S., Keats, J. J., Cibulskis, K., Sougnez, C. L., Schinzel, A. C., Harview, C. L., Brunet, J.-P., Ahmann, G. J., Adli, M., et al. (2011) · Nature · doi:10.1038/nature09837 · Cited by 1,457

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome

Ley, T. J., Mardis, E. R., Ding, L., Fulton, B., McLellan, M. D., Chen, K., Dooling, D. J., Dunford-Shore, B. H., McGrath, S. D., Hickenbotham, M. T., et al. (2008) · Nature · doi:10.1038/nature07485 · Cited by 1,434

Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms

Palomo, L., Meggendorfer, M., Hütter, S., Twardziok, S. O., Ademà, V., Fuhrmann, I., Fuster‐Tormo, F., Xicoy, B., Zamora, L., Acha, P., et al. (2020) · Blood · doi:10.1182/blood.2019004229 · Cited by 175

Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria

Shen, W., Clemente, M. J., Hosono, N., Yoshida, K., Przychodzen, B. P., Yoshizato, T., Shiraishi, Y., Miyano, S., Ogawa, S., Maciejewski, J. P., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74747 · Cited by 176

Recent developments in myelodysplastic syndromes

Bejar, R. L., & Steensma, D. P. (2014) · Blood · doi:10.1182/blood-2014-04-522136 · Cited by 179

SRSF2 Regulates Alternative Splicing to Drive Hepatocellular Carcinoma Development

Luo, C., Cheng, Y., Liu, Y., Chen, L., Liu, L., Wei, N., Xie, Z., Wu, W., & Feng, Y. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1919 · Cited by 174

Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia

Meldi, K. M., Qin, T., Buchi, F., Droin, N. M., Sotzen, J. R., Micol, J., Selimoglu‐Buet, D., Masala, E., Allione, B., Gioia, D. M., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78752 · Cited by 184

Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia

Beekman, R., Valkhof, M. G., Sanders, M. A., van Strien, P., Haanstra, J. R., Broeders, L., Geertsma-Kleinekoort, W. M. C., Veerman, A. J. P., Valk, P. J. M., Verhaak, R. G. W., et al. (2012) · Blood · doi:10.1182/blood-2012-01-406116 · Cited by 174

Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia

Shiozawa, Y., Malcovati, L., Gallì, A., Sato‐Otsubo, A., Kataoka, K., Sato, Y., Watatani, Y., Suzuki, H., Yoshizato, T., Yoshida, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06063-x · Cited by 179

Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†☆

Fenaux, P., Haase, D. T., Santini, V., Sanz, G. F., Platzbecker, U., & Mey, U. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.11.002 · Cited by 176

Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Fenaux, P., Haase, D. T., Sanz, G. F., Santini, V., & Buske, C. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu180 · Cited by 174

A Pan-Cancer Analysis of Transcriptome Changes Associated with Somatic Mutations in U2AF1 Reveals Commonly Altered Splicing Events

Brooks, A. N., Choi, P. S., de Waal, L. M., Sharifnia, T., Imielinski, M. B., Saksena, G., Pedamallu, C. S., Sivachenko, A., Rosenberg, M. W., Chmielecki, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087361 · Cited by 173

Clinical Implications of Genetic Mutations in Myelodysplastic Syndrome

Kennedy, J. A., & Ebert, B. L. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.0806 · Cited by 175

The U1 spliceosomal RNA is recurrently mutated in multiple cancers

Shuai, S., Suzuki, H., Díaz‐Navarro, A., Nadeu, F., Kumar, S. A., Gutiérrez‐Fernández, A., Delgado, J., Pinyol, M., López-Otı́n, C., Puente, X. S., et al. (2019) · Nature · doi:10.1038/s41586-019-1651-z · Cited by 169

Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation

Gibson, C. J., Kim, H. T., Zhao, L., Murdock, H. M., Hambley, B., Ogata, A., Madero-Marroquin, R., Wang, S., Green, L., Fleharty, M., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02286 · Cited by 168

SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survival

Lasho, T. L., Jimma, T., Finke, C. M., Patnaik, M. M., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., & Tefferi, A. (2012) · Blood · doi:10.1182/blood-2012-05-429696 · Cited by 176

Spliceosome Mutations Induce R Loop-Associated Sensitivity to ATR Inhibition in Myelodysplastic Syndromes

Nguyen, H. D., Leong, W. Y., Li, W., Reddy, P. N. G., Sullivan, J. D., Walter, M. J., Zou, L., & Graubert, T. A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3970 · Cited by 169

Germ line DDX41 mutations define a unique subtype of myeloid neoplasms

Makishima, H., Saiki, R., Nannya, Y., Korotev, S. C., Gurnari, C., Takeda, J., Momozawa, Y., Best, S., Krishnamurthy, P., Yoshizato, T., et al. (2022) · Blood · doi:10.1182/blood.2022018221 · Cited by 165

Modulating splicing with small molecular inhibitors of the spliceosome

Effenberger, K. A., Urabe, V. K., & Jurica, M. S. (2016) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1381 · Cited by 161

Functional Splicing Network Reveals Extensive Regulatory Potential of the Core Spliceosomal Machinery

Papasaikas, P., Tejedor, J. R., Vigevani, L., & Valcárcel, J. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.10.030 · Cited by 172

Dysregulation and therapeutic targeting of RNA splicing in cancer

Stanley, R. F., & Abdel-Wahab, O. I. (2022) · Nature Cancer · doi:10.1038/s43018-022-00384-z · Cited by 172

Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms

Brecqueville, M., Rey, J., Bertucci, F., Coppin, E., Finetti, P., Carbuccia, N., Cervera, N., Gelsi‐Boyer, V., Arnoulet, C., Gisserot, O., et al. (2012) · Genes Chromosomes and Cancer · doi:10.1002/gcc.21960 · Cited by 168

Splicing factor mutations and cancer

Yoshida, K., & Ogawa, S. (2014) · WIREs RNA · doi:10.1002/wrna.1222 · Cited by 155

Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: Prevalence, clinical correlates, and prognostic relevance

Patnaik, M. M., Lasho, T. L., Finke, C. M., Hanson, C. A., Hodnefield, J. M., Knudson, R. A., Ketterling, R. P., Pardanani, A. D., & Tefferi, A. (2012) · American Journal of Hematology · doi:10.1002/ajh.23373 · Cited by 156

GM-CSF–dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia

Padron, E., Painter, J. S., Kunigal, S., Mailloux, A. W., McGraw, K. L., McDaniel, J. M., Kim, E. H., Bebbington, C. R., Baer, M., Yarranton, G. T., et al. (2013) · Blood · doi:10.1182/blood-2012-10-460170 · Cited by 154

The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution

Wu, S., Kuo, Y., Hou, H., Li, L.-Y., Tseng, M., Huang, C., Lee, F., Liu, M.-C., Liu, C., Lin, C., et al. (2012) · Blood · doi:10.1182/blood-2012-02-412296 · Cited by 158

Myeloid malignancies: mutations, models and management

Murati, A., Brecqueville, M., Devillier, R., Mozziconacci, J., Gelsi‐Boyer, V., & Birnbaum, D. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-304 · Cited by 163

Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing

Dolnik, A., Engelmann, J. C., Scharfenberger‐Schmeer, M., Mauch, J. A., Kelkenberg-Schade, S., Haldemann, B., Fries, T., Krönke, J., Kühn, M. W. M., Paschka, P., et al. (2012) · Blood · doi:10.1182/blood-2011-12-401471 · Cited by 162

Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms

Cazzola, M., Rossi, M., & Malcovati, L. (2012) · Blood · doi:10.1182/blood-2012-09-399725 · Cited by 154

The pathogenicity of splicing defects: mechanistic insights into pre‐mRNA processing inform novel therapeutic approaches

Daguenet, É., Dujardin, G., & Valcárcel, J. (2015) · EMBO Reports · doi:10.15252/embr.201541116 · Cited by 159

Clonal evolution in myelodysplastic syndromes

da Silva-Coelho, P., Kroeze, L. I., Yoshida, K., Koorenhof‐Scheele, T. N., Knops, R., van de Locht, L. T., de Graaf, A. O., Massop, M., Sandmann, S., Dugas, M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15099 · Cited by 158

Poison Exon Splicing Regulates a Coordinated Network of SR Protein Expression during Differentiation and Tumorigenesis

Leclair, N. K., Brugiolo, M., Urbanski, L. M., Lawson, S. C., Thakar, K., Yurieva, M., George, J., Hinson, J. T., Cheng, A. W., Graveley, B. R., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.10.019 · Cited by 150

Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms

Przychodzen, B. P., Jerez, A., Guinta, K. M., Sekeres, M. A., Padgett, R. A., Maciejewski, J. P., & Makishima, H. (2013) · Blood · doi:10.1182/blood-2013-01-480970 · Cited by 155

How we treat lower-risk myelodysplastic syndromes

Fenaux, P., & Adès, L. (2013) · Blood · doi:10.1182/blood-2013-02-453068 · Cited by 150

Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing

Selvanathan, S. P., Graham, G. T., Erkizan, H. V., Dirksen, U., Natarajan, T. G., Dakic, A., Yu, S., Liu, X., Paulsen, M. T., Ljungman, M. E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500536112 · Cited by 153

Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes

Porta, M. G. D., Travaglino, E., Boveri, E., Ponzoni, M., Malcovati, L., Papaemmanuil, E., Rigolin, G. M., Pascutto, C., Croci, G. A., Gianelli, U., et al. (2014) · Leukemia · doi:10.1038/leu.2014.161 · Cited by 149

SF3B1 mutations in chronic lymphocytic leukemia

Wan, Y., & Wu, C. J. (2013) · Blood · doi:10.1182/blood-2013-02-427641 · Cited by 155

Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer

Korpal, M., Puyang, X., Wu, Z. J., Seiler, R., Furman, C., Oo, H. Z., Seiler, M., Irwin, S., Subramanian, V., Joshi, J. J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00147-w · Cited by 147

RNA components of the spliceosome regulate tissue- and cancer-specific alternative splicingPreprint

Dvinge, H., Guenthoer, J., Porter, P. L., & Bradley, R. K. (2019) · Genome Research · doi:10.1101/gr.246678.118 · Cited by 147

The genetics of uveal melanoma: current insights

Höiom, V., & Helgadóttir, H. (2016) · The Application of Clinical Genetics · doi:10.2147/tacg.s69210 · Cited by 142

Building Robust Transcriptomes with Master Splicing Factors

Jangi, M., & Sharp, P. A. (2014) · Cell · doi:10.1016/j.cell.2014.09.054 · Cited by 141

Altered RNA Processing in Cancer Pathogenesis and Therapy

Obeng, E. A., Stewart, C., & Abdel-Wahab, O. I. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0399 · Cited by 145

Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis

Saiki, R., Momozawa, Y., Nannya, Y., Nakagawa, M. M., Ochi, Y., Yoshizato, T., Terao, C., Kuroda, Y., Shiraishi, Y., Chiba, K., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01411-9 · Cited by 143

An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies

Padron, E., Garcia‐Manero, G., Patnaik, M. M., Itzykson, R., Lasho, T. L., Nazha, A., Rampal, R. K., Sanchez, M. E., Jabbour, E. J., Ali, N. H. A., et al. (2015) · Blood Cancer Journal · doi:10.1038/bcj.2015.53 · Cited by 140

The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes

Raza, A., & Galili, N. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3321 · Cited by 150

Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients

Christen, F., Hoyer, K., Yoshida, K., Hou, H., Waldhüter, N., Heuser, M., Hills, R. K., Chan, W., Hablesreiter, R., Blau, O., et al. (2019) · Blood · doi:10.1182/blood-2018-05-852822 · Cited by 144

Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a M ayo C linic‐ F rench C onsortium S tudy

Wassie, E. A., Itzykson, R., Lasho, T. L., Kosmider, O., Finke, C. M., Hanson, C. A., Ketterling, R. P., Solary, É., Tefferi, A., & Patnaik, M. M. (2014) · American Journal of Hematology · doi:10.1002/ajh.23846 · Cited by 139

miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signaling

Bhagat, T. D., Zhou, L., Sokol, L., Kessel, R. M., Cáceres, G., Gundabolu, K., Tamari, R., Gordon, S. A. K., Mantzaris, I., Jodlowski, T., et al. (2013) · Blood · doi:10.1182/blood-2011-12-397067 · Cited by 139

Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia

Seki, M., Kimura, S., Isobe, T., Yoshida, K., Ueno, H., Nakajima-Takagi, Y., Wang, C., Lin, L., Kon, A., Suzuki, H., et al. (2017) · Nature Genetics · doi:10.1038/ng.3900 · Cited by 138

CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor

Funnell, T., Tasaki, S., Oloumi, A., Araki, S., Kong, E., Yap, D., Nakayama, Y., Hughes, C. S., Cheng, S., Tozaki, H., et al. (2017) · Nature Communications · doi:10.1038/s41467-016-0008-7 · Cited by 139

Engaging chromatin: PRC2 structure meets function

Chammas, P., Mocavini, I., & Croce, L. D. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0615-2 · Cited by 149

Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia

Patnaik, M. M., & Tefferi, A. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2016.5 · Cited by 137

Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes

Dolatshad, H., Pellagatti, A., Liberante, F. G., Llorian, M., Repapi, E., Steeples, V., Roy, S., Scifo, L., Armstrong, R. N., Shaw, J. M., et al. (2016) · Leukemia · doi:10.1038/leu.2016.149 · Cited by 144

Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management

Patnaik, M. M., & Tefferi, A. (2019) · American Journal of Hematology · doi:10.1002/ajh.25684 · Cited by 139

The molecular genetics of sideroblastic anemia

Ducamp, S., & Fleming, M. D. (2019) · Blood · doi:10.1182/blood-2018-08-815951 · Cited by 136

Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia

Shih, A. H., Chung, S. S., Dolezal, E. K., Zhang, S.-J., Abdel-Wahab, O. I., Park, C. Y., Nimer, S. D., Levine, R. L., & Klimek, V. M. (2013) · Haematologica · doi:10.3324/haematol.2012.076729 · Cited by 135

U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicing

Okeyo-Owuor, T., White, B. S., Chatrikhi, R., Mohan, D. R., Kim, S. P., Griffith, M., Ding, L., Ketkar-Kulkarni, S., Hundal, J., Laird, K. M., et al. (2014) · Leukemia · doi:10.1038/leu.2014.303 · Cited by 137

Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)

Porta, M. G. D., Tuechler, H., Malcovati, L., Schanz, J., Sanz, G. F., Garcia‐Manero, G., Solé, F. G., Bennett, J. M., Bowen, D., Fenaux, P., et al. (2015) · Leukemia · doi:10.1038/leu.2015.55 · Cited by 139

Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use

Bacher, U., Shumilov, E., Flach, J., Porret, N. A., Joncourt, R., Wiedemann, G., Fiedler, M., Novak, U., Amstutz, U., & Pabst, T. (2018) · Blood Cancer Journal · doi:10.1038/s41408-018-0148-6 · Cited by 136

Emerging roles of spliceosome in cancer and immunity

Yang, H., Beutler, B., & Zhang, D. (2021) · Protein & Cell · doi:10.1007/s13238-021-00856-5 · Cited by 135

An RNA-Seq atlas of gene expression in mouse and rat normal tissues

Söllner, J. F., Leparc, G., Hildebrandt, T., Klein, H., Thomas, L., Stupka, E., & Simon, E. (2017) · Scientific Data · doi:10.1038/sdata.2017.185 · Cited by 133

Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy

Kim, T., Tyndel, M. S., Kim, H. J., Ahn, J.-S., Choi, S. H., Park, H. J., Kim, Y.-K., Kim, S. Y., Lipton, J. H., Zhang, Z., et al. (2017) · Blood · doi:10.1182/blood-2016-04-708560 · Cited by 133

Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies

Khan, S. N., Jankowska, A. M., Mahfouz, R. Z., Dunbar, A. J., Sugimoto, Y., Hosono, N., Hu, Z., Cheriyath, V., Vatolin, S., Przychodzen, B. P., et al. (2013) · Leukemia · doi:10.1038/leu.2013.80 · Cited by 139

Genomic landscape of liposarcoma

Kanojia, D., Nagata, Y., Garg, M., Lee, D. H., Sato, A., Yoshida, K., Sato, Y., Sanada, M., Mayakonda, A., Bartenhagen, C., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6464 · Cited by 136

Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes

Unnikrishnan, A., Papaemmanuil, E., Beck, D., Deshpande, N., Verma, A., Kumari, A., Woll, P. S., Richards, L. A., Knezevic, K., Chandrakanthan, V., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.067 · Cited by 137

U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 Pre-mRNA 3′ End Formation

Park, S. M., Ou, J., Chamberlain, L., Simone, T. M., Yang, H., Virbasius, C.-M. A., Ali, A. M., Zhu, L. J., Mukherjee, S., Raza, A., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.04.011 · Cited by 135

Splicing factor gene mutations in hematologic malignancies

Sáez, B., Walter, M. J., & Graubert, T. A. (2016) · Blood · doi:10.1182/blood-2016-10-692400 · Cited by 134

Rbfox2 controls autoregulation in RNA-binding protein networksPreprint

Jangi, M., Boutz, P. L., Paul, P., & Sharp, P. A. (2014) · Genes & Development · doi:10.1101/gad.235770.113 · Cited by 136

Clonal hematopoiesis: Mutation-specific adaptation to environmental change

Florez, M. A., Tran, B. T., Wathan, T. K., DeGregori, J., Pietras, E. M., & King, K. Y. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.05.006 · Cited by 129

Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failure

Mossner, M., Jann, J.-C., Wittig, J., Nolte, F., Fey, S., Nowak, V., Obländer, J., Pressler, J., Palme, I., Xanthopoulos, C., et al. (2016) · Blood · doi:10.1182/blood-2015-11-679167 · Cited by 135

Translational implications of somatic genomics in acute myeloid leukaemia

Meyer, S. C., & Levine, R. L. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70008-7 · Cited by 139

iReckon: Simultaneous isoform discovery and abundance estimation from RNA-seq dataPreprint

Mezlini, A. M., Smith, E. J. M., Fiume, M., Buske, O., Savich, G. L., Shah, S., Aparicio, S. A. J. R., Chiang, D. Y., Goldenberg, A., & Brudno, M. (2012) · Genome Research · doi:10.1101/gr.142232.112 · Cited by 128

Mutational spectrum of adult T-ALL

Neumann, M., Vosberg, S., Schlee, C., Heesch, S., Schwartz, S., Gökbuget, N., Hoelzer, D. F., Graf, A., Krebs, S., Bartram, I., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2218 · Cited by 127

Disease-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1

Zhang, J., Ali, A. M., Lieu, Y. K., Liu, Z., Gao, J., Rabadán, R., Raza, A., Mukherjee, S., & Manley, J. L. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.017 · Cited by 127

Serine/arginine-rich splicing factors: the bridge linking alternative splicing and cancer

Zheng, X., Qiu, P., Wang, L., Zhang, X., Huang, L., Wang, J., & Qin, Z. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.46751 · Cited by 123

Overview: An iPS cell stock at CiRA

Umekage, M., Sato, Y., & Takasu, N. (2019) · Inflammation and Regeneration · doi:10.1186/s41232-019-0106-0 · Cited by 122

Alternative transcription and alternative splicing in cancer

Pal, S., Gupta, R., & Davuluri, R. V. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.005 · Cited by 128

Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts

Mupo, A., Seiler, M., Sathiaseelan, V., Pance, A., Yang, Y., Agrawal, A. A., Iorio, F., Bautista, R., Pacharne, S., Tzelepis, K., et al. (2016) · Leukemia · doi:10.1038/leu.2016.251 · Cited by 128

PRPF8 defects cause missplicing in myeloid malignancies

Kurtović-Kozarić, A., Przychodzen, B. P., Singh, J., Konarska, M. M., Clemente, M. J., Otrock, Z. K., Nakashima, M. O., Hsi, E. D., Yoshida, K., Shiraishi, Y., et al. (2014) · Leukemia · doi:10.1038/leu.2014.144 · Cited by 123

RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML

Crews, L. A., Balaian, L., Santos, N. P. D., Leu, H. S., Court, A. C., Lazzari, E., Sadarangani, A., Zipeto, M., Clair, J. J. L., Villa, R., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.08.003 · Cited by 123

ETV6 in hematopoiesis and leukemia predisposition

Hock, H. R., & Shimamura, A. (2017) · Seminars in Hematology · doi:10.1053/j.seminhematol.2017.04.005 · Cited by 121

RNA editing-dependent epitranscriptome diversity in cancer stem cells

Jiang, Q., Crews, L. A., Holm, F., & Jamieson, C. H. M. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.23 · Cited by 120

DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation

Close, P., East, P., Dirac-Svejstrup, A. B., Hartmann, H., Heron, M., Maslen, S., Chariot, A., Söding, J., Skehel, M., & Svejstrup, J. Q. (2012) · Nature · doi:10.1038/nature10925 · Cited by 119

Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization

Liu, Z., Yoshimi, A., Wang, J., Cho, H., Chun-Wei Lee, S., Ki, M., Bitner, L., Chu, T., Shah, H., Liu, B., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1330 · Cited by 118

Mutant U2AF1-expressing cells are sensitive to pharmacological modulation of the spliceosome

Shirai, C. L., White, B. S., Tripathi, M., TAPIA-CONYER, R. C., Ley, J. N., Ndonwi, M., Kim, S. P., Shao, J., Carver, A., Sáez, B., et al. (2017) · Nature Communications · doi:10.1038/ncomms14060 · Cited by 122

Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells

Pan, F., Wingo, T. S., Zhao, Z., Gao, R., Makishima, H., Qu, G., Lin, L., Yu, M., Ortega, J. R., Wang, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms15102 · Cited by 117

SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients

Lasho, T. L., Finke, C. M., Hanson, C. A., Jimma, T., Knudson, R. A., Ketterling, R. P., Pardanani, A. D., & Tefferi, A. (2011) · Leukemia · doi:10.1038/leu.2011.320 · Cited by 117

The molecular pathogenesis of the myelodysplastic syndromes

Pellagatti, A., & Boultwood, J. (2015) · European Journal Of Haematology · doi:10.1111/ejh.12515 · Cited by 120

SnapShot: Splicing Alterations in Cancer

Rahman, M. A., Krainer, A. R., & Abdel-Wahab, O. I. (2020) · Cell · doi:10.1016/j.cell.2019.12.011 · Cited by 116

The Arabidopsis lncRNA ASCO modulates the transcriptome through interaction with splicing factors

Rigo, R., Bazin, J., Romero-Barrios, N., Moison, M., Lucero, L. E., Christ, A., Benhamed, M., Blein, T., Huguet, S., Charon, C., et al. (2020) · EMBO Reports · doi:10.15252/embr.201948977 · Cited by 117

Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations

Durham, B. H., Getta, B. M., Dietrich, S., Taylor, J., Won, H. H., Bogenberger, J. M., Scott, S. N., Kim, E. H., Chung, Y. R., Chung, S. S., et al. (2017) · Blood · doi:10.1182/blood-2017-01-765107 · Cited by 119

Co-Design for A64FX Manycore Processor and ”Fugaku”

Sato, M., Ishikawa, Y., Tomita, H., Kodama, Y., Odajima, T., Tsuji, M., Yashiro, H., Aoki, M., Shida, N., Miyoshi, I., et al. (2020) · International Conference for High Performance Computing, Networking, Storage and Analysis (SC) · doi:10.1109/sc41405.2020.00051 · Cited by 114

Dysregulation of spliceosome gene expression in advanced prostate cancer by RNA-binding protein PSF

Takayama, K., Suzuki, T., Fujimura, T., Yamada, Y., Takahashi, S., Homma, Y., Suzuki, Y., & Inoue, S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706076114 · Cited by 114

Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy

Quidville, V., Alsafadi, S., Goubar, A., Commo, F., Scott, V., Pioche‐Durieu, C., Girault, I., Baconnais, S., Cam, É. L., Lazar, V., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2501 · Cited by 112

Aberrant splicing isoforms detected by full-length transcriptome sequencing as transcripts of potential neoantigens in non-small cell lung cancer

Oka, M., Xu, L., Suzuki, T., Yoshikawa, T., Sakamoto, H., Uemura, H., Yoshizawa, A. C., Suzuki, Y., Nakatsura, T., Ishihama, Y., et al. (2021) · Genome biology · doi:10.1186/s13059-020-02240-8 · Cited by 115

Synthetically Lethal Interactions of ATM, ATR, and DNA-PKcs

Kantidze, O. L., Velichko, A. K., Luzhin, A. V., Petrova, N. V., & Razin, S. V. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.09.007 · Cited by 112

Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management

Patnaik, M. M., & Tefferi, A. (2018) · American Journal of Hematology · doi:10.1002/ajh.25104 · Cited by 110

Integrative analysis revealed the molecular mechanism underlying RBM10‐mediated splicing regulation

Wang, Y., Gogol‐Döring, A., Hu, H., Fröhler, S., Ma, Y., Jens, M., Maaskola, J., Murakawa, Y., Quedenau, C., Landthaler, M., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302663 · Cited by 112

Genomic determinants of chronic myelomonocytic leukemia

Patel, B. J., Przychodzen, B. P., Thota, S., Radivoyevitch, T., Visconte, V., Kuzmanovic, T., Clemente, M. J., Hirsch, C. M., Morawski, A. R., Souaid, R., et al. (2017) · Leukemia · doi:10.1038/leu.2017.164 · Cited by 109

Spliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesisPreprint

Inoue, D., Bradley, R. K., & Abdel-Wahab, O. I. (2016) · Genes & Development · doi:10.1101/gad.278424.116 · Cited by 112

SF3B1 Association with Chromatin Determines Splicing Outcomes

Kfir, N., Lev-Maor, G., Glaich, O., Alajem, A., Datta, A., Sze, S. K., Meshorer, E., & Ast, G. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.048 · Cited by 108

Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing

Shibuya, Y., Tokunaga, H., Saito, S., Shimokawa, K., Katsuoka, F., Li, B., Kojima, K., Nagasaki, M., Yamamoto, M. P., Yaegashi, N., et al. (2017) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22507 · Cited by 112

Abstract 5119: Frequent splicing pathway mutations and aberrant RNA splicing in myelodysplasia

Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato‐Otsubo, A., Kon, A., Nagasaki, M., et al. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-5119 · Cited by 4

Mutational Spectrum Analysis of Interesting Correlation and Interrelationship Between RNA Splicing Pathway and Commonly Targeted Genes in Myelodysplastic Syndrome

Nagata, Y., Sanada, M., Kon, A., Yoshida, K., Shiraishi, Y., Sato‐Otsubo, A., Mori, H., Ishiyama, K., Sakata‐Yanagimoto, M., Obara, N., et al. (2011) · Blood · doi:10.1182/blood.v118.21.273.273 · Cited by 3

Pathway Mutations in the Splicing Machinery in Myeloid Neoplasms

Ogawa, S. (2012) · Blood · doi:10.1182/blood.v120.21.sci-14.sci-14

Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes

Madan, V., Li, J., Zhou, S., Teoh, W. W., Han, L., Meggendorfer, M., Malcovati, L., Cazzola, M., Ogawa, S., Haferlach, T., et al. (2019) · American Journal of Hematology · doi:10.1002/ajh.25673 · Cited by 22

Splicing factor mutations in myelodysplasia

Ogawa, S. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1182-y · Cited by 38